IAG will Present at American Society of Clinical Oncology (ASCO), May 29-31, 2020

IAG will Present at American Society of Clinical Oncology (ASCO), May 29-31, 2020

IAG, Image Analysis Group, a strategic partner to life-sciences companies developing novel treatment, today announced that IAG’s team will present two abstracts at this year’s American Society Clinical Oncology Virtual Conference, ASCO20.

The abstracts are based upon the data from IAG’s latest clinical research studies and discuss how advanced imaging, radiomics and machine learning-augmented analysis can assist with patient phenotyping and cancer drug development.

The accepted abstracts are:

Title:Amide proton transfer MRI can accurately stratify gliomas according to their IDH mutation and 1p/19q co-deletion status.” 
Presenter: Prof. Sotirios Bisdas & Dr. Diana Dupont-Roettger

Title:Performance of machine learning-augmented analysis of radiomics for the head and neck cancer histopathological diagnosis: A systematic review and meta-analysis.
Presenter: Prof. Sotirios Bisdas & Dr. Diana Dupont-Roettger

Full publication released by ASCO on May 13, 2020, at 5:00 PM EST  on www.abstracts.asco.org

To learn more about IAG’s work in oncology, join our scientific leadership team on a LIVE webinar:  Join IAG’s scientists on a live webinar to learn more about our research efforts in Neuro-Oncology.

Send your questions to imaging.experts@ia-grp.com

Prof. Sotirios Bisdas is IAG’s Sn Director of Neuro-Oncology Research. He is a consultant neuroradiologist and MRI Lead in the Department of Neuroradiology at the National Hospital for Neurology in London, Senior Lecturer in Neuroradiology at the Institute of Neurology University College London, and Professor of Radiology at Eberhard Karls University in Tübingen, Germany. He has authored over 130 peer-reviewed publications and serves as member of the editorial board of several leading journals in Radiology and Neuroradiology. He is also reviewer for leading journals in Neuroimaging, member of the Executive Committee of the European Society of Head and Neck Radiology, and member of the Head and Neck committee of the European Society of Neuroradiology.

Dr. Diana Dupont-Roettger is Chief Scientific Alliance Officer. She is a Medical Computer Scientist by background with strong experience in novel imaging technologies and imaging markers and their role in clinical trials. She advises biopharmaceutical companies on the strategic use of advanced imaging to evaluate mechanism of action, enable precision medicine and accelerate drug development in immuno-oncology and neuro-oncology indications. Diana is actively working with biotech, pharma and investment funds helping to bridge the gap between academic research, business objectives and finances.

About IAG:

 IAG, Image Analysis Group is a strategic partner to bio-pharmaceutical companies developing new treatments to improve patients’ lives. IAG broadly leverages its core imaging expertise, proprietary technology platform DYNAMIKA and capabilities to support an objective early go no/ go decision and drive excellence for tomorrow’s innovative therapeutic agents with speed. We fuse decades of therapeutic insights, risk-sharing business model and agile culture to accelerate novel drug development. www.ia-grp.com

If you are interested in meeting our expert team at ASCO’20 Virtual Conference please email <imaging.experts@ia-grp.com>

News
Events